Evaluation of seroepidemiological toxoplasmosis in HIV/AIDS patients in the south of Brazil;Avaliação soroepidemiológica de toxoplasmose em pacientes HIV/SIDA no sul do Brasil

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 55, Issue 1, 2013, Pages 25-30

  Xavier, Graciela Augusto ^a   Cademartori, Beatris Gonzalez ^a   da Cunha Filho, Nilton Azevedo ^a   Farias, Nara Amélia da Rosa ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

AIDS; Neurotoxoplasmosis; Ocular toxoplasmosis; Toxoplasma gondii; Toxoplasmosis

Indexed keywords

ANTIRETROVIRUS AGENT; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; AGED; AIDS PATIENT; ANTIBODY TITER; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; FEMALE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PARASITE PREVALENCE; PARASITE TRANSMISSION; QUESTIONNAIRE; RISK FACTOR; SEROEPIDEMIOLOGY; SEROPREVALENCE; SEX DIFFERENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 84872793120     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652013000100005     Document Type: Article

References (31)

1. Alves JM, Magalhães V, de Matos MAG. Retinocoroidite toxoplásmica em pacientes com AIDS e neurotoxoplasmose. Arq Bras Oftalmol. 2010;73:150-4.
2. Antinori A, Larussa D, Cingolani A, Lorenzini P, Bossolasco S, Finazzi MG, et al. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis. 2004;39:1681-91.
3. Bhaskar R. Seronegative central nervous system toxoplasmosis in HIV/AIDS. Internet J Intern Med. 2005;5(2):9.
4. Cademartori BG, Farias NAR, Brod CS. Soroprevalência e fatores de risco à infecção por Toxoplasma gondii em gestantes de Pelotas, sul do Brasil. Rev Panam Infectol. 2008;10:30-5.
5. Camara VD, Tavares W, Ribeiro M, Dumas M. Manifestações neurológicas de toxoplasmose em AIDS. DST-J Bras Doenças Sex Transm. 2003;15(2):46-50.
6. Contini C. Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient. Parassitologia. 2008;50:45-50.
7. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000;321(7254):142-7.
8. del Rio-Chiriboga C, Orzechowski-Rallo A, Sanchez-Mejorada G. Toxoplasmosis of the central nervous system in patients with AIDS in Mexico. Arch Med Res. 1997;28:527-30.
9. Dias RAF, Freire RL. Surtos de toxoplasmose em seres humanos e animais. Semina Cienc Agrar. 2005;26:239-48.
10. Diniz EMA. O diagnóstico da toxoplasmose na gestante e no recém-nascido. Pediatria (S. Paulo). 2006;28:222-5.
11. Dubey JP. Sources of Toxoplasma gondii infection in pregnancy. Until rates of congenital toxoplasmosis fall, control measures are essential. BMJ. 2000;321:127-8.
12. Dunlop O, Rootwelt V, Sannes M, Goplen AK, Abdelnoor M, Skaug K, et al. Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis. Scand J Infect Dis. 1996;28:71-3.
13. do Carmo EL, Silva MCM, Xavier UAM, da Costa BO, Póvoa MM. Inquérito sorológico de toxoplasmose em candidatos a transplante renal no Hospital Ofir Loyola, Belém, Pará, Brasil. Rev Panam Infectol. 2004;6(4):15-7.
14. Gomides MDA, Berbert ALCV, Mantese SAO, Rocha A, Ferreira MS, Borges AS. Dermatoses em pacientes com Aids: estudo de 55 casos. Rev Assoc Med Bras. 2002;48:36-41.
15. Holland GN, Engstrom RE Jr, Glasgow BJ, Berger BB, Daniels SA, Sidikaro Y, et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1988;106:653-67.
16. Kawasaki ML, Carvalho PN, Lucarevschi BR. Atenção à toxoplasmose durante a gestação em população carente do interior do estado de São Paulo. Pediatria (S. Paulo). 2006;28:242-50.
17. Loges LA, Cademartori BG, Farias NAR. Seroprevalence and associated factors to Toxoplasma gondii infection in blood donors in Southern Brazil. Rev Panam Infectol. 2012;14(1):27-31.
18. Lopes FMR, Mitsuka-Breganó R, Gonçalves DD, Freire RL, Karigyo CJT, Wedy GF, et al. Factors associated with seropositivity for anti-Toxoplasma gondii antibodies in pregnant women of Londrina, Paraná, Brazil. Mem Inst Oswaldo Cruz. 2009;104:378-82.
19. Matos KTF, Santos MCM, Muccioli C. Manifestações oculares do paciente infectado pelo HIV atendido no Departamento de Oftalmologia da Universidade Federal de São Paulo. Rev Assoc Med Bras. 1999;45: 323-6.
20. Ministério da Saúde. Brasil. Secretaria de Vigilância em Saúde. Programa Nacional de DST e AIDS. Recomendações para terapia antirretroviral em adultos infectados pelo HIV. Brasília: SVS/PNDST AIDS; 2008. [Cited: 2011, Oct 13]. Available from: http://www.aids.gov.br/data/documents/stored
21. Mohraz M, Mehrkhani F, Jam S, Seyedalinaghi SA, Sabzvari D, Fattahi F, et al. Seroprevalence of toxoplasmosis in HIV (+) /AIDS patients in Iran. Acta Med Iran. 2011;49:213-8.
22. Nissapatorn V, Lee C, Quek KF, Leong CL, Mahmud R, Abdullah KA. Toxoplasmosis in HIV/AIDS patients: a current situation. Jpn J Infect Dis. 2004;57:160-5.
23. Nunes CLX, Gonçalves LA, Silva PT, Bina JC. Características clinicoepidemiológicas de um grupo de mulheres com HIV/AIDS em Salvador-Bahia. Rev Soc Bras Med Trop. 2004;37:436-40.
24. Sitoe SPBL, Rafael B, Meireles RL, de Andrade Junior HF, Thompson R. Preliminary report of HIV and Toxoplasma gondii occurrence in pregnant women from Mozambique. Rev Inst Med Trop Sao Paulo. 2010;52:291-5.
25. Sotolongo PC, Carrillo PC, Carrillo CC. Toxoplasmosis cerebral durante la infección por el virus de inmunodeficiencia humana. Rev Cuba Med. 2002;41:297-302.
26. Spalding SM, Amendoeira MRR, Ribeiro LC, Silveira C, Garcia AP, Camillo-Coura L. Estudo prospectivo de gestantes e seus bebês com risco de transmissão de toxoplasmose congênita em município do Rio Grande do Sul. Rev Soc Bras Med Trop. 2003;36:483-91.
27. Teixeira MG, Silva GA. La representación del portador de virus de inmunodeficiencia humana sobre el tratamiento antirretroviral. Rev Esc Enferm USP. 2008;42:729-36.
28. Varella IS, Wagner MB, Darela AC, Nunes, LM, Müller RW. Seroprevalence of toxoplasmosis in pregnant women. J Pediatr (Rio J). 2003;79:69-74.
29. Wallace GR, Stanfort MR. Immunity and Toxoplasma retinochoroiditis. Clin Exp Immunol. 2008;153:309-15.
30. Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. Int J Parasitol. 2009;39:895-901.
31. Zajdenweber M, Muccioli C, Belfort R Jr. Acometimento ocular em pacientes com AIDS e toxoplasmose do sistema nervoso central-antes e depois do HAART. Arq Bras Oftalmol. 2005;68:773-5.